Daxor Return on Tangible Equity 2010-2011 | DXR

Current and historical return on tangible equity values for Daxor (DXR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Daxor Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2011-12-31 $-0.01B $0.04B -14.46%
2011-09-30 $0.00B $0.04B -6.78%
2011-06-30 $0.00B $0.05B 8.56%
2011-03-31 $0.00B $0.05B 8.70%
2010-12-31 $0.01B $0.05B 10.81%
2010-09-30 $0.00B $0.05B 4.30%
2010-06-30 $0.00B $0.04B 4.26%
2010-03-31 $0.01B $0.05B 16.84%
2009-12-31 $0.01B $0.05B 13.71%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.046B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.382B 19.10
Encompass Health (EHC) United States $11.869B 25.16
DaVita (DVA) United States $10.709B 15.06
Elanco Animal Health (ELAN) United States $7.340B 15.72
Chemed (CHE) United States $6.899B 21.68
Option Care Health (OPCH) United States $5.017B 22.36
RadNet (RDNT) United States $4.323B 274.38
Amedisys (AMED) United States $3.213B 21.61
Addus HomeCare (ADUS) United States $2.105B 23.11
LifeStance Health (LFST) United States $1.847B 0.00
Astrana Health (ASTH) United States $1.391B 34.47
U.S Physical Therapy (USPH) United States $1.162B 29.99
Pennant (PNTG) United States $0.902B 33.11
Aveanna Healthcare Holdings (AVAH) United States $0.833B 47.44
Atai Life Sciences (ATAI) Germany $0.533B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.040B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00